T he pathogen Helicobacter pylori, a microaerophilic Gramnegative bacterium, is considered to be the main cause of peptic ulcers and a risk factor for gastric cancer and MALT (mucosa-associated lymphoid tissue) lymphoma.
1,2 Although its role is debatable, this bacterium has also been associated with nondigestive manifestations 3 such as Raynaud's phenomenon, 4 ,5 cardiovascular diseases, 6, 7 Sjögren's syndrome, 8, 9 urticaria, 10 and rosacea. 11, 12 Eye involvement is common in rosacea, including chronic conjunctivitis (3% of all chronic conjunctivitis), blepharitis, chalazia, and keratitis. Therefore, it is reasonable to postulate a role of H. pylori infection in ophthalmic diseases such as chronic ocular inflammation 13 and glaucoma. 14, 15 Moreover, the prevalence of HP infection has been found to be significantly higher in central serous chorioretinopathy-affected subjects. 16, 17 We studied the prevalence of H. pylori infection in patients with chronic blepharitis and its relationship to conjunctival cytology results.
MATERIALS AND METHODS
The Ethics Board of the Department of Neurosciences, Ophthalmology and Genetics, Clinica Oculistica, Genoa University, approved the study. The protocol prescribed the prospective recruitment of 500 patients. The blepharitis group, selected in our ophthalmic section, comprised 250 consecutive patients with chronic symptomatic blepharitis. The control group consisted of another 250 consecutive patients selected in the Gastroenterology Department, to verify the prevalence of H. pylori infection in patients without ophthalmic symptoms. Patients with blepharitis with chronic systemic diseases and patients on long-term therapy with topical eye drops and with diseases such as atopic dermatitis were excluded. The research followed the tenets of the Declaration of Helsinki.
All diagnoses of blepharitis were performed by means of an ophthalmic examination, including slit lamp examination with lissamine green and fluorescein staining, tear break-up time, and Schirmer's test. Patients were classified according to McCulley's criteria (Table 1) . 18, 19 Impression cytology was performed in all patients by pressing a 6 ϫ 8-mm cellulose acetate paper sheet (Hwap 304 FO; Millipore, Bedford, MA) on different locations of the bulbar conjunctiva and then staining the adherent cell layer with Gill's modified Papanicolaou stain, according to the technique described by Tseng. 20 To interpret the results, we used the morphologic characteristics summarized in Table 2 . A conjunctival swab was also obtained from subjects in the blepharitis group, to evaluate the microbiologic flora. One horse blood agar plate and one chocolate agar plate were inoculated with each conjunctival swab. The plates were placed in an incubator set to 35°C with 5% CO 2 . All plates were observed daily for 7 days for the formation of microbial colonies. The bacteria were identified with kits (Analytab Products, Inc., Plainview, NY), in conjunction with appropriate supplementary tests, by using standard microbiologic techniques. 21 A dermatologist evaluated all patients. All underwent laboratory blood examinations (red cell binding, PRIST [paper radioimmunosorbent test], RAST [radioallergosorbent test], and prick test) to exclude any allergic disorder. Patients with clinical signs of atopic dermatitis were excluded from the study. Those in the blepharitis group with chronic systemic diseases were also excluded. Dermatologists reported the concomitant presence of dermatological signs (Table 3) , confirming the clinical diagnosis.
All enrolled patients confirmed their voluntary participation in the study by signing an informed consent form, after explanation of the nature and possible consequences of the study.
All patients underwent the 13 C-urea breath test (UBT) 23, 24 specifically for H. pylori infection. UBT remains the first-line noninvasive test for the assessment of the efficacy of anti-H. pylori treatment and has been validated by some studies for sensitivity and specificity superior to 90%. 25 UBT-positive (UBT ϩ ) patients underwent 1 week of triple therapy:
a combination of 400 mg ranitidine bismuth citrate twice daily, 250 mg clarithromycin twice daily, and 500 mg metronidazole twice daily. 26 Tear substitutes were added. All patients underwent impression cytology 40 Ϯ 12 days (SD) after eradication of the H. pylori infection. Patients who were still UBT ϩ after eradication treatment underwent another cycle of therapy, with the following therapeutic regimen for 10 days: 20 mg omeprazole twice daily, 500 mg tetracycline twice daily, and 500 mg tinidazole twice daily. Impression cytology was repeated 1 month later (80 Ϯ 9 days from the beginning of follow-up).
Follow-up was approximately 4 months Ϯ 28 days. If patients became UBT negative (UBT Ϫ ) after impression cytology, they were withdrawn from the study. At the end of follow-up, the UBT Ϫ patients were also withdrawn, after undergoing a further impression cytology Classically, these signs are present; however, in this analysis anterior and posterior were grouped. Seborrheic blepharitis always has some manifestation of meibomitis; rosacea blepharitis has staphylococcal contamination. Therefore, the clinical division of anterior and posterior was not observed. Well delineated borders Good intercellular cohesion N/C ratio 1/1 1/2
A, cell diameter; N/C ratio, nucleus/cytoplasm ratio. Consecutive patients recruited at the Gastroenterology Department were investigated with questions that were intended to exclude the possibility of the presence of any ophthalmic symptom. The question put to each of the patients in the control group was: "Do you suffer from eye irritation? For example: burning, soreness, redness, lacrimation, foreign body sensation, or itching in one or both of your eyes?" Patients who replied in the affirmative, even if only for one symptom, were excluded from the study. We established 5 years as the minimum period without symptoms for patients to be enrolled in the study.
All patients recruited as control subjects were apparently healthy and had no specific symptoms. They had been referred to the Gastroenterology Section to undergo 13 C-urea breath testing, because they were exposed to the risk of H. pylori infection (e.g., cohabiting with infected persons). All underwent UBT and were examined by slit lamp to verify the presence of blepharitis.
To evaluate the results, all data were considered as relative percentages and analyses were conducted on computer (StatView software; Abacus Concepts Inc., Berkeley, CA). The 2 test was used to test for differences in age and time groups at P Ͻ 0.05. All data are presented in Table 4 , both as the number of cases and as percentages.
RESULTS
Ninety-nine patients did not complete the study (56 did not comply with follow-up, 27 took drugs incompatible with our protocol, and 16 had to undergo surgery). Therefore, 401 patients were included in the analysis: 186 with chronic blepharitis in the blepharitis group, and 215 without ophthalmic symptoms in the control group (see the flow diagram in Fig. 1) .
The age and sex of patients are shown in Table 4 . In the blepharitis group, seborrheic blepharitis was observed in 94 (50.4%) patients, rosacea blepharitis in 72 (38.7%), and mixed blepharitis in 20 (10.8%; Table 5 ). On objective examination, blepharitis was also found in 66 UBT ϩ control subjects (31.7%), even though they were completely free of symptoms. In the blepharitis group, the prevalence of seborrheic blepharitis showed a tendency to decrease with age, whereas the prevalence of rosacea blepharitis tended to increase. However, the 2 test was not significant (Table 5 ). In UBT Ϫ control subjects, blepharitis was found in 29 (13.4%) patients.
The most common bacteria identified in the patients with blepharitis were Staphylococcus epidermidis (93.8%), Propionibacterium acnes (79.2%), Corynebacterium sp. (71.2%), Staphylococcus aureus (16%) and Acinetobacter sp. (12.1%). No difference was found in the distribution of these bacteria between the UBT ϩ and UBT Ϫ subjects (Table 6 ). The culture examination was not performed in the control group.
The rate of H. pylori infection was proportionally higher with increasing age in the three groups of patients-less than 40 years, 40 to 60 years, and more than 60 years-with a remarkable difference between the blepharitis and control groups ( 2 ϭ 49, 136 df ϭ 5, P Ͻ 0.0001; Table 7 ). H. pylori infection, detected by means of UBT, was found in 233 (58%) patients and was significantly more common in patients with blepharitis (76%) than in control subjects (42%; 2 ϭ 47.231, P Ͻ 0.01) and in people older than 60 years (42%) than in younger people (26%; 2 ϭ 49.1, P ϭ 0.002; Table 7 ). A comparison of ophthalmic patients with control subjects showed a significant difference between patients with and without blepharitis ( 2 ϭ 116.0, P Ͻ 0.001), but no difference was found between patients with blepharitis coming from the two different departments (Gastroenterology and Ophthalmology; 2 ϭ 0.29, P ϭ 0.58). Hence, blepharitis symptoms were independent of the H. pylori infection.
In the patients with blepharitis, the distribution of morphologic type of blepharitis did not show a statistically significant difference between UBT ϩ and UBT Ϫ subjects (Table 8) . Impression cytology did not show different patterns based on the clinical type of blepharitis, because the differences probably depended on the age of the patient. Indeed, there was a morphologic and functional decline with age, which was easily verifiable by means of impression cytology, both in normal patients and in patients with blepharitis (Fig. 2) . Furthermore, there was a substantial difference in cytology between UBT ϩ and UBT Ϫ patients with blepharitis (Fig. 3) . After the first cycle of therapy, 188 (80.6%) patients became free of H. pylori infection. After the second, infection was eradicated in another 28 (12.1%) patients, and at the end of follow-up 17 (7.3%) patients remained UBT ϩ . Of this last group, eight (3.4%) had rosacea, seven (3%) seborrhea, and two (0.85%) mixed blepharitis (P ϭ 0.538; see flow diagram in Fig. 1 ).
In the 208 UBT ϩ patients with blepharitis (n ϭ 142 ϩ 66, see Fig. 1 ), after eradication therapy, cytologic patterns remained similar in 50% of cases (n ϭ 105). Nevertheless, we observed a remarkable improvement in 35% of the cases (n ϭ 73)-that is, an increase in the number of cells and a better cytologic morphology. According to our classification (Table  2) , we observed a class transition across at least two subclasses-for example, from 2a to 3b. In 15% of cases (31 For a diagnosis of blepharitis, one or more lesions must be observed on the eyelid margin with a nongranulomatous inflammatory reaction associated. patients), the improvement was slight, consisting only of an increase in the number of cells-that is, from 1b to 2a.
In particular, from a clinical standpoint, a remarkable improvement was observed in 37 (18%) patients with rosacea, in 27 (13%) with chronic seborrheic blepharitis, and in 9 (4.5%) with mixed blepharitis. However, there was no statistically significant difference between the patients with rosacea and those with seborrheic blepharitis (P ϭ 0.872).
In UBT Ϫ patients with blepharitis (n ϭ 29 patients), in whom the only therapy administered was 2% hyaluronic acid sodium salt at the end of the follow-up, we noted a marked improvement in 3.4% of cases and a slight improvement in 10.3%. The remaining 86.3% did not show any clinical changes.
FIGURE 1. Flow diagram of subjects'
progress through the phases of study. The patients were selected in the Ophthalmology and Gastroenterology departments during the whole period of the study and were placed in two groups: patients with symptomatic blepharitis (n ϭ 186) and control subjects who had no symptoms of blepharitis (n ϭ 215). After undergoing UBT, these groups were subdivided into UBT ϩ and UBT Ϫ . The UBT ϩ patients were treated with up to a maximum of two cycles of therapy to eradicate Helicobacter infection. At the end of the follow-up, UBT Ϫ patients from the control group left the study after undergoing further impression cytology. *Patients who completed therapy and left the study after testing negative on the second UBT. The distribution of the bacteria in the two groups does not show a significant difference P Ͼ 0.5. Among the patients in whom the infection was eradicated, no recurrence was noted, although we cannot rule out the possibility that there may have been some recurrence among the patients who exited the study during follow-up.
DISCUSSION
Blepharitis is a very common disease in elderly patients. Seborrheic dermatitis is the most common cause of anterior lamellar or marginal blepharitis, whereas blepharitis of the posterior lamella is due to meibomian gland dysfunction. Eyelid margins have focal or diffuse inflammation, with telangiectasia around the meibomian gland orifices. 18 Several other factors play an etiologic role, including exogenous irritants and allergens, staphylococcal infection, and rosacea. 19 Patients with rosacea often report digestive disturbances, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] which have been considered to be directly related to blepharitis. 28 Digestive troubles are related more to rosacea than to seborrhea, 27 although there is much that binds these two pathologic conditions. 29 There seems to be a connection between H. pylori infection and rosacea, 11 whereas the association between seborrhea and H. pylori, which has been reported in another study, 30 seems to be more uncertain. Moreover, seborrheic dermatitis may be seen in conjunction with other skin diseases, such as rosacea, blepharitis, or ocular rosacea, and acne vulgaris. 31 It can therefore be claimed, albeit with some uncertainty, that digestive troubles correlate with the presence of blepharitis, or, in any case, that their association is likely.
Our study confirms that the relation between blepharitis and H. pylori infection is not influenced by its clinical appearance or degree, 32 and it seems that the only common factor is chronic inflammation of the eyelid and gastrointestinal tract.
From a cytological point of view, blepharitis demonstrates a diversity in whether the UBT result is positive or negative. However, there is no correlation with its subjective symptoms, as happens in chronic gastritis caused by H. pylori.
H. pylori infection may explain this intriguing relationship. The infection may also induce lid inflammatory changes by several mechanisms. First, H. pylori produces nitric oxide and gastrin, 33 both potent vasodilators that may play a role in producing flushing reactions on the face and neck. Eyelids and conjunctiva are certainly involved in vasodilation, and this effect may be the starting point of a chronic inflammation. Second, the chronic release of large amounts of inflammatory mediators caused by H. pylori infection or, more likely, cross- 21 (9) 28 (12) 42 (18) Data are the number of patients (percentage of the total group). The number of positive results on the UBT increased with age, remaining, however, significantly different between the two groups. See also Figure 1 . 
In the patients with blepharitis, no statistically significant difference was observed between UBT ϩ and UBT Ϫ patients in the distribution of the type of conjunctivitis. Data are the number of patients. 
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Correlation between H. pylori and Blepharitis 505 mimicry mechanisms between bacterial and extradigestive antigens, could affect extradigestive organs. 34, 35 Indeed, rosacea could be considered one of the major extragastric diseasecomplex associations of H. pylori infection, probably mediated by H. pylori-related cytotoxins and cytokines. 13, 36 Third, H. pylori has been found in the mouth, 37 but it is not known whether the oral cavity acts as a permanent reservoir for this bacterium. 38 However, from the oral cavity, it may reach the anterior surface of the eye, causing blepharitis or worsening it, at least on the basis of cytological criteria (Fig. 2) .
Blepharitis in approximately 50% of our patients improved after eradication treatment of H. pylori. This was especially so in the case of younger patients, in whom blepharitis has often been reported to be associated with rosacea. 39 It is important to stress that oral metronidazole has been successfully used in blepharitis with rosacea, 40, 41 though the beneficial effects of metronidazole in acne vulgaris are attributable to its anti-inflammatory activities rather than to its antibacterial ones. 42 Furthermore, the antibiotic therapy used acts not only against H. pylori infection but also against lid bacteria, particularly Staphylococcus (Ͼ90% in our sample; see Table 6 ), which can influence the clinical appearance of blepharitis. Therefore, the improvement we observed might be the result of the combined therapeutic action on H. pylori infection and lid bacteria. It is known that the associations between chronic blepharitis and eyelid meibomian gland lipids and microflora involve important relationships between these lipids and chronic blepharitis disease states. Moreover, antibiotics like tetracycline can inhibit lipase activity and therefore decrease the release of noxious free fatty acids, 43 thereby resulting in decreased bacteriologic lipase activity. 44, 45 Indeed, therapeutic results of systemic antibiotics in the treatment of blepharitis have recently been reported. 46 However, in our study, the clinical improvements were obtained after the eradication of H. pylori infection (Fig. 2) .
Except in the case of Staphylococcus pathogenesis, 47 blepharitis is not completely resolved. Usually, the antibiotic therapy is intended to reduce the microbial proliferation that has a direct or indirect role in chronic blepharitis. 48 Systemic antibiotic therapy may be helpful in patients with meibomian gland dysfunction 39 or in cases of rosacea. 40 Moreover, metronidazole has been used successfully in patients with blepharitis with resistant rosacea. 41, 48 Symptoms of dry eye are complex and variable. An important and causal relationship can exist between H. pylori and blepharitis without a strong treatment effect, and elements of the treatment are standard for blepharitis already. Other elements of the treatment are not.
The complex interactions between H. pylori infection and the eye is another field of ongoing research, though the association remains unclear. The precise pathophysiology of central serous chorioretinopathy is also uncertain. Choroidal microcirculation abnormalities, vascular wall antigens and antibody reactivity could be involved. 49, 50 H. pylori infection may influence the pathophysiology of glaucoma by releasing various proinflammatory and vasoactive substances, as well as by influencing the apoptotic process, parameters that may also exert their own effects in the induction and/or progression of glaucomatous neuropathy. 51 It is possible that the "link" is the oxidative damage that recurs in circulation disorders, 52 in inflammation, [53] [54] [55] and in glaucoma. 56 Indeed, H. pylori infection could affect the pathophysiology of glaucoma, by producing oxidative stress and circulating lipid peroxides, 55 and may contribute to central serous chorioretinopathy by increasing endothelin 1, nitric oxide, 57 and inducible nitric oxide synthase and releasing proinflammatory and vasoactive substances. The latter substances may be involved in the pathophysiology of blepharitis.
In conclusion, our data seem to confirm a relationship between chronic blepharitis and H. pylori infection, even though they may not indicate a causal association. However, we recommend that caution be exercised in interpreting the results, as possible sources of error must be considered in defining the association of two highly prevalent conditions. Although the exact role of H. pylori infection in chronic inflammation of the eyelids is unknown, eradication of H. pylori by means of the antibiotic therapy described herein improves conjunctival cytology, and can, especially in the young, alleviate blepharitis. In any case, chronic blepharitis is a disorder of great interdisciplinary interest, in that it may be a clinical sign of an internal infection.
Further studies to elucidate the role of H. pylori infection in the pathogenesis of blepharitis are therefore indicated.
FIGURE 3. Impression cytology in UBT
ϩ patients with blepharitis, before and after eradication treatment. UBT ϩ specimens showed a lower cell number and more worse morphology than those from noninfected patients. In these patients, too, cytology findings worsened with age. Improvement in cytology was observed in approximately 50% of cases after eradication. 
